Literature DB >> 2522688

Atrial natriuretic peptide concentrations in hypoxic secondary pulmonary hypertension: relation to haemodynamic and blood gas variables and response to supplemental oxygen.

R J Winter1, A C Davidson, D Treacher, R M Rudd, J V Anderson, L Meleagros, S R Bloom.   

Abstract

Plasma atrial natriuretic peptide concentrations, measured in samples drawn from the pulmonary artery, were raised in nine of 17 patients with hypoxic pulmonary hypertension but normal right atrial pressures at rest. No relationship was seen between atrial natriuretic peptide concentrations and mean pulmonary artery or right atrial pressure, or calculated pulmonary or systemic vascular resistance. Patients with the most severe hypoxaemia tended to have higher plasma atrial natriuretic peptide concentrations; three patients with no past history of oedema had concentrations more than twice the upper limit of normal. Treatment with supplementary oxygen for 30 minutes reduced pulmonary vascular resistance in all patients but had no significant effect on plasma atrial natriuretic peptide concentration. These findings suggest that atrial natriuretic peptide may be a factor in the control of sodium and water balance in hypoxic cor pulmonale, where the determinants of individual susceptibility to peripheral oedema are not well understood.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522688      PMCID: PMC461665          DOI: 10.1136/thx.44.1.58

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  16 in total

1.  The effect of changes in body sodium on extracellular fluid volume and aldosterone and sodium excretion by normal and edematous men.

Authors:  F C BARTTER; L E DUNCAN; G W LIDDLE
Journal:  J Clin Invest       Date:  1956-11       Impact factor: 14.808

Review 2.  Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.

Authors:  J H Laragh
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

Review 3.  Endocrine factors in congestive heart failure.

Authors:  J Genest; P Granger; J De Champlain; R Boucher
Journal:  Am J Cardiol       Date:  1968-07       Impact factor: 2.778

4.  A pathophysiological study of 10 cases of hypoxic cor pulmonale.

Authors:  M Wilkinson; C A Langhorne; D Heath; G R Barer; P Howard
Journal:  Q J Med       Date:  1988-01

5.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

6.  Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension.

Authors:  S Adnot; P E Chabrier; P Andrivet; I Viossat; J Piquet; C Brun-Buisson; Y Gutkowska; P Braquet
Journal:  Am Rev Respir Dis       Date:  1987-10

7.  Atrial natriuretic peptide levels in plasma and in cardiac tissues after chronic hypoxia in rats.

Authors:  R J Winter; L Meleagros; S Pervez; H Jamal; T Krausz; J M Polak; S R Bloom
Journal:  Clin Sci (Lond)       Date:  1989-01       Impact factor: 6.124

8.  Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease.

Authors:  R M Timms; F U Khaja; G W Williams
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

9.  Atrial natriuretic peptide inhibits the effect of endogenous angiotensin II on plasma aldosterone in conscious sodium-depleted rats.

Authors:  L Chartier; E L Schiffrin
Journal:  Clin Sci (Lond)       Date:  1987-01       Impact factor: 6.124

10.  The plasma release of atrial natriuretic peptide in man.

Authors:  J V Anderson; J Donckier; W J McKenna; S R Bloom
Journal:  Clin Sci (Lond)       Date:  1986-08       Impact factor: 6.124

View more
  6 in total

Review 1.  Renal and hormonal abnormalities in chronic obstructive pulmonary disease (COPD).

Authors:  P Palange
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

2.  Gentamicin volume of distribution in critically ill septic patients.

Authors:  C Triginer; I Izquierdo; R Fernández; J Rello; J Torrent; S Benito; A Net
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

3.  Atrial natriuretic peptide in stable and decompensated chronic obstructive pulmonary disease.

Authors:  K Skwarski; M Lee; L Turnbull; W MacNee
Journal:  Thorax       Date:  1993-07       Impact factor: 9.139

4.  Short term effect of oxygen on renal haemodynamics in patients with hypoxaemic chronic obstructive airways disease.

Authors:  S V Baudouin; J Bott; A Ward; C Deane; J Moxham
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

5.  Neutral endopeptidase (NEP) inhibition in rats with established pulmonary hypertension secondary to chronic hypoxia.

Authors:  J S Thompson; W Sheedy; A H Morice
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

6.  Changes in atrial natriuretic peptide concentrations during intravenous saline infusion in hypoxic cor pulmonale.

Authors:  A G Stewart; P A Bardsley; S V Baudouin; J C Waterhouse; J S Thompson; A H Morice; P Howard
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.